Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06030687 · ClinicalTrials.gov registry record
FoodImage 3 Free-Living
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT06030687: Completed study, sponsored by Pennington Biomedical Research Center.
NCT06030687 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06030687 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Participants will be asked to use the app to capture data on food purchases, food waste that occurs during food preparation, food waste that is present after eating, and food waste from cabinet and refrigerator/freezer clean-outs. During collection of much of the food waste data, participants will record in the app if food waste will be disposed of via composting, disposal, fed to pets, or garbage/landfill. They will also indicate if the food was spoiled, past the expiration date, etc. This will occur for 4-8 days. Participants should perform the prep and eat occasions 4-8 days. The shopping and toss occasions should be completed for at least 7 days.
Primary Outcome
weight (g)
Interventions
- OTHER Ad libitum data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2024-08-27 |
What the finished NCT06030687 record still lists
NCT06030687 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ad libitum data collection is the first listed.
NCT06030687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06030687 about?
NCT06030687 is a clinical study titled "FoodImage 3 Free-Living". Participants will be asked to use the app to capture data on food purchases, food waste that occurs during food preparation, food waste that is present after eating, and food waste from cabinet and refrigerator/freezer clean-outs. During collection of much of the food waste data, participants will r...
What is the current status of trial NCT06030687?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2024-01-10. Estimated completion is 2024-08-27.
What interventions are being tested in trial NCT06030687?
The interventions under investigation include: Ad libitum data collection (OTHER).
Who is sponsoring clinical trial NCT06030687?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI